More on DAWN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $12.78 |
|
|||
| Open | $21.13 | ||||
| 52 Wk High | $0.01 | ||||
| 52 Wk Low | $0.00 | ||||
| Day High | $21.23 | ||||
| Day Low | $21.08 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 78,371,925 | ||||
- Shareholder Alert: The Ademi Firm investigates whether Day One Biopharmaceuticals, Inc. is obtaining a Fair Price for its Public Shareholders
- $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN)
- TD Cowen Downgrades Day One Biopharmaceuticals (DAWN) to Hold: "justifiable acquisition value"
- Oppenheimer Reiterates Perform Rating on Day One Biopharmaceuticals (DAWN): "management made the right call to sell now"
- Needham Downgrades Day One Biopharmaceuticals (DAWN) to Hold
- Piper Sandler Downgrades Day One Biopharmaceuticals (DAWN) to Neutral
- Wedbush Downgrades Day One Biopharmaceuticals (DAWN) to Neutral
- Jones Trading Downgrades Day One Biopharmaceuticals (DAWN) to Hold following sale to Servier
- Form SC TO-C Day One Biopharmaceutica Filed by: Day One Biopharmaceuticals, Inc.
- Form SC14D9C Day One Biopharmaceutica Filed by: Day One Biopharmaceuticals, Inc.
Entities mentioned with DAWN
- Definitive Agreement | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Twitter | View Related Stories »
- Cowen & Co | View Related Stories »
- JPMorgan | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Show More...
